Format

Send to

Choose Destination
Crit Care Nurs Clin North Am. 2016 Sep;28(3):309-16. doi: 10.1016/j.cnc.2016.04.005. Epub 2016 Jun 7.

Paroxysmal Supraventricular Tachycardia: Pathophysiology, Diagnosis, and Management.

Author information

1
Department of Acute and Tertiary Care, School of Nursing, University of Pittsburgh, 3500 Victoria Street, 336 VB, Pittsburgh, PA 15261, USA. Electronic address: ssa33@pitt.edu.
2
Department of Acute and Tertiary Care, School of Nursing, University of Pittsburgh, 3500 Victoria Street, 336 VB, Pittsburgh, PA 15261, USA.

Abstract

Paroxysmal supraventricular tachycardia (PSVT) is a well-known and thoroughly studied clinical syndrome, characterized by regular tachycardia rhythm with sudden onset and abrupt termination. Most patients present with palpitations and dizziness, and their electrocardiogram demonstrates a narrow QRS complex and regular tachycardia with hidden or inverted P waves. PSVT is caused by re-entry due to the presence of inhomogeneous, accessory, or concealed conducting pathways. Hemodynamically stable patients are treated by vagal maneuvers, intravenous adenosine, diltiazem, or verapamil, hemodynamically unstable patients are treated by cardioversion. Patients with symptomatic and recurrent PSVT can be treated with long-term drug treatment or catheter ablation.

KEYWORDS:

Accessory pathways; Paroxysmal supraventricular tachycardia; Supraventricular arrhythmia; Wolff-Parkinson-White syndrome

PMID:
27484659
DOI:
10.1016/j.cnc.2016.04.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center